Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
Promoting physical activity to control multiple sclerosis from childhood.
Role of autophagy in the pathogenesis of multiple sclerosis.
The grey matter correlates of impaired decision-making in multiple sclerosis.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
The Challenges for Drug Development: Cytokines, Genes, and Stem Cells.
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
[Clinical validity of the quantitative gait variables in patients with multiple sclerosis. A comparison of the Timed 25-foot Walk Test and the GAITRite ® Electronic Walkway system].
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Vitamin D - immunomodulatory actions and new potentialities.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Immunosuppressive treatments in multiple sclerosis.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis.
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
Distinguishing Susac's syndrome from multiple sclerosis.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Pages
« first
‹ previous
…
261
262
263
264
265
266
267
268
269
…
next ›
last »